Background Accurate prediction of DNA motifs that are targets of RNA polymerases, sigma
factors and transcription factors (TFs) in prokaryotes is a difficult mission mainly due to as yet …

Traditionally, flow cytometry has been the preferred method to characterize immune cells at
the single-cell level. Flow cytometry is used in immunology mostly to measure the expression …

T cell development in the mouse thymus has been studied extensively, but less is known
regarding T cell development in the human thymus. We used a combination of single-cell …

Recombinase-activating gene-1 (RAG1)-deficient severe combined immunodeficiency (SCID)
patients lack B and T lymphocytes due to the inability to rearrange immunoglobulin and T …

T cell factor 1 (Tcf1) is the first T cell–specific protein induced by Notch signaling in the
thymus, leading to the activation of two major target genes, Gata3 and Bcl11b. Tcf1 deficiency …

Bevacizumab (bvz) is currently employed as an anti-angiogenic therapy across several cancer
indications. Bvz response heterogeneity has been well documented, with only 10-15% of …

We set out to develop an autologous preclinical strategy to generate functional human thymi
from induced pluripotent stem cells (iPSCs). We adapted the differentiation approach …

Purpose Patients with metastatic colorectal cancer (mCRC) have limited benefit from the
addition of bevacizumab to standard chemotherapy. However, a subset probably benefits …

Background Patients with longstanding inflammatory bowel disease (IBD; ie, ulcerative colitis
and Crohn’s disease) have an increased risk of colorectal cancer (CRC). Due to ongoing …

RAG2 severe combined immune deficiency (RAG2-SCID) is a lethal disorder caused by the
absence of functional T and B cells due to a differentiation block. Here, we generated …